A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterus.

@article{Wolfson2007AGO,
  title={A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterus.},
  author={Aaron H. Wolfson and Mark F. Brady and Thomas F Rocereto and Robert Mannel and Y Lee and Robert J Futoran and David Cohn and Olga B. Ioffe},
  journal={Gynecologic oncology},
  year={2007},
  volume={107 2},
  pages={177-85}
}
PURPOSE After initial surgery, there has been no established consensus regarding adjunctive therapy for patients with uterine carcinosarcoma (CS). This study was designed to compare patient outcome following treatment with adjuvant whole abdominal irradiation (WAI) versus (vs.) chemotherapy for patients with this rare group of female pelvic malignancies. PATIENTS AND METHODS Eligible, consenting women with stage I-IV uterine CS, no more than 1 cm postsurgical residuum and/or no extra… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 63 extracted citations

Similar Papers

Loading similar papers…